media – Page 748 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

UK launch for Bayer’s five-year contraceptive Kyleena

A new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has been launched in the UK.
- Source: pharmatimes
- 533
- February 12, 2018
Kyleena Researches unplanned pregnancy
ViiV kicks off PhIII trial of two-drug HIV regimen

ViiV Healthcare, an HIV specialist firm majority owned by GlaxoSmithKline, has announced the launch of a late-stage study investigating the effectiveness of a two-drug regimen programme in patients with HIV.
- Source: pharmatimes
- 887
- February 12, 2018
Clinical Trial HIV Phase TANGO
Risk-averse ACOs miss out on nearly $1B in savings

A vast majority of accountable-care organizations in zero-risk contracts would reap additional savings if they took on downside risk because of the bonuses incurred as an advanced alternative payment model under MACRA, a new analysis finds.
- Source: modernhealthcare
- 596
- February 12, 2018
ACOs Market Views
4 causes of failure for medical devices

Materials are one of the most common causes of failure in medical devices, especially for plastic. Records show that material failure is responsible for 30 to 40 percent of all FDA recalls on medical devices.
- Source: multibriefs
- 968
- February 12, 2018
Market Views medical device
Best tech tools to communicate with patients? Time for doctors to ask

Cultivating a strong relationship with patients can translate into higher satisfaction scores but there is a widespread failure to communicate about the most appropriate way to reach consumers.
- Source: healthcareitnews
- 609
- February 12, 2018
healthcare Market Views
Major fertility breakthrough as human eggs grown in lab for first time

Human eggs have been fully grown in a laboratory for the first time in what has been hailed as a majorfertility breakthrough.
- Source: msn
- 819
- February 11, 2018
Human eggs majorfertility Researches
Genentech’s Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

Genentech’s PD-L1 inhibitor Tecentriq continues to show off its versatility. Monday, the Roche subsidiary announced a combination of Tecentriq and Avastin (bevacizumab) was significantly beneficial to patients with advanced or metastatic renal cell carcinoma (mRCC) who have not received prior systemic active or experimental therapy.
- Source: Biospace
- 959
- February 11, 2018
Clinical Trial inhibitor mRCC Tecentriq
Scientists discover way to halt breast cancer spread

Scientists have uncovered a key mechanism that facilitates the spread of breast cancer cells, and thus a potential target for new therapeutic approaches in the fight against the disease.
- Source: pharmatimes
- 713
- February 11, 2018
breast cancer L-asparaginase Researches
Janssen Enters Into Worldwide Collaboration With Theravance Biopharma For Oral, Pan-JAK Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of Theravance Biopharma, Inc. to develop TD-1473, a first-in-class oral, gastrointestinal (GI) restricted pan-Janus kinase (JAK) inhibitor for the treatment of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis (UC).
- Source: prnewswire
- 949
- February 11, 2018
Crohn’s disease IBD Janssen Johnson & Johnson ulcerative colitis
Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate

A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate.
- Source: MedCityNews
- 1,000
- February 11, 2018
FDA financing Market Views prostate

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.